Filing Details
- Accession Number:
- 0001209191-16-090363
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-07 16:46:34
- Reporting Period:
- 2016-01-05
- Filing Date:
- 2016-01-07
- Accepted Time:
- 2016-01-07 16:46:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1253886 | G Patrick Enright | C/O Longitude Capital Partners, Llc 800 El Camino Real, Suite 220 Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2016-01-05 | 5,746 | $137.71 | 229,538 | No | 4 | S | Indirect | By Longitude Venture Partners, L.P. |
| Ordinary Shares | Disposition | 2016-01-05 | 2,843 | $138.36 | 226,695 | No | 4 | S | Indirect | By Longitude Venture Partners, L.P. |
| Ordinary Shares | Disposition | 2016-01-05 | 1,214 | $139.24 | 225,481 | No | 4 | S | Indirect | By Longitude Venture Partners, L.P. |
| Ordinary Shares | Disposition | 2016-01-05 | 116 | $137.71 | 4,600 | No | 4 | S | Indirect | By Longitude Capital Associates, L.P. ( |
| Ordinary Shares | Disposition | 2016-01-05 | 57 | $138.37 | 4,543 | No | 4 | S | Indirect | By Longitude Capital Associates, L.P. |
| Ordinary Shares | Disposition | 2016-01-05 | 24 | $139.24 | 4,519 | No | 4 | S | Indirect | By Longitude Capital Associates, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Longitude Venture Partners, L.P. |
| No | 4 | S | Indirect | By Longitude Venture Partners, L.P. |
| No | 4 | S | Indirect | By Longitude Venture Partners, L.P. |
| No | 4 | S | Indirect | By Longitude Capital Associates, L.P. ( |
| No | 4 | S | Indirect | By Longitude Capital Associates, L.P. |
| No | 4 | S | Indirect | By Longitude Capital Associates, L.P. |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 1,310 | Direct |
Footnotes
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.06 to $138.0573. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- The Reporting Person is a managing member of Longitude Capital Partners, LLC, the general partner of each of Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. The Reporting Person disclaims beneficial ownership of the securities of the Issuer held by Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. except to the extent of his pecuniary interest therein.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $138.0887 to $138.9478. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $139.09 to $139.43. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.06 to $138.0573. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $138.0887 to $138.9478. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $139.09 to $139.43. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Billionaire Hedge Funds
